Klinikum Schwabing

Hospital


Location: München, Germany (DE) DE

ISNI: 0000000093313436

ROR: https://ror.org/002bjfj29

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in Germany (2016) Jockenhoefer F, Gollnick H, Herberger K, Isbary G, Renner R, Stuecker M, Valesky E, et al. Journal article Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV (2016) Miranda MB, Lauseker M, Kraus MP, Proetel U, Hanfstein B, Fabarius A, Baerlocher GM, et al. Journal article Long-term Surveillance of Children with Congenital Hypothyroidism: Data from the German Registry for Congenital Hypothyroidism (AQUAPE "Hypo Dok") (2015) Ellerbroek VL, Bonfig W, Dörr HG, Bettendorf M, Hauffa B, Fricke-Otto S, Rohrer T, et al. Journal article Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies (2015) Boehm M, Schumacher H, Schmieder R, Mann JFE, Teo K, Lonn E, Sleight P, et al. Journal article Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV (2014) Kalmanti L, Saussele S, Lauseker M, Proetel U, Mueller MC, Hanfstein B, Schreiber A, et al. Journal article Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV (2014) Hehlmann R, Müller MC, Lauseker M, Hanfstein B, Fabarius A, Schreiber A, Proetel U, et al. Journal article
‹ 1 2 3 4 ›